WallStreetZen

NYSE: JNJ
Johnson & Johnson Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

JNJ past earnings growth

How has JNJ's earnings growth performed historically?
Company
-2.27%
Industry
13.35%
Market
37.62%
JNJ's earnings have grown slower (0.11% per year) than the US Drug Manufacturers - General industry average (4.06%)
Performance
JNJ's earnings have grown slower (0.11% per year) than the US market average (19.73%)
Performance
JNJ's earnings growth is slowing down - its growth over the last year (-2.27%) is below its 5-year compound annual rate (0.11%)
Performance

JNJ past revenue growth

How has JNJ's revenue growth performed historically?
Company
0.64%
Industry
12.11%
Market
20.3%
JNJ's revenue has grown slower (3.34% per year) than the US Drug Manufacturers - General industry average (5.94%)
Performance
JNJ's revenue has grown slower (3.34% per year) than the US market average (18.37%)
Performance
JNJ's revenue growth is slowing down - its growth over the last year (0.64%) is below its 5-year compound annual rate (3.34%)
Performance

JNJ earnings and revenue history

Current Revenue
$82.6B
Current Earnings
$14.7B
Current Profit Margin
17.8%
JNJ's has not demonstrated consistent long-term earnings growth over the past 10 years (15.26%)
Performance

JNJ Return on equity

Current Company
23.4%
Current Industry
35.6%
Current Market
49.8%
JNJ's Return on Equity (23.4%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

JNJ Return on assets

Current Company
8.9%
Current Industry
6.9%
Current Market
5.4%
JNJ is generating higher Return on Assets (8.9%) than the US Drug Manufacturers - General industry average (7.12%)
Performance

JNJ Return on capital employed

Current Company
12.61%
Current Industry
11.1%
JNJ's ability to generate Return on Capital (12.61%) has decreased compared to 3 years ago (14.68%)
Performance

JNJ earnings dates

Next earnings date
Apr 20, 2021

Johnson & Johnson Earnings & Revenue FAQ

What were JNJ's earnings last quarter?

On Jan 26, 2021, Johnson & Johnson (NYSE: JNJ) reported Q4 2020 earnings per share (EPS) of $0.66, up 56.86% year over year. Total Johnson & Johnson earnings for the quarter were $1.74 billion. In the same quarter last year, Johnson & Johnson's earnings per share (EPS) was $1.53.

What was JNJ's earnings growth in the past year?

As of Q2 2021, Johnson & Johnson's earnings has grown -2.27% year over year. This is 15.63 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 13.35%. Johnson & Johnson's earnings in the past year totalled $14.71 billion.

What is JNJ's earnings date?

Johnson & Johnson's earnings date is Apr 20, 2021. Add JNJ to your watchlist to be reminded of JNJ's next earnings announcement.

What was JNJ's revenue last quarter?

On Jan 26, 2021, Johnson & Johnson (NYSE: JNJ) reported Q4 2020 revenue of $22.48 billion up 8.33% year over year. In the same quarter last year, Johnson & Johnson's revenue was $20.75 billion.

What was JNJ's revenue growth in the past year?

As of Q2 2021, Johnson & Johnson's revenue has grown 0.64% year over year. This is 11.47 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.11%. Johnson & Johnson's revenue in the past year totalled $82.58 billion.
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.